All News

What was the 19th century tonic that was meant to be a meat substitute for those who could not afford it?

Top news of the week from Pharmacy Times®.

Walgreens and DoorDash plan to offer more than 5000 items for delivery on the DoorDash platform and will expand the service to other major markets, starting with Cincinnati, Cleveland, Minneapolis, Oklahoma City, Phoenix, Sacramento, and Seattle by the end of summer 2020.

New molecules could the brain’s immune system to better control epilepsy.

Pharmacy Times spoke with Jessica Langely, MS, executive director of education and advocacy, about the importance of expanding the role of pharmacy technicians.

New ruling means up to 126,400 women of childbearing age may need to pay out-of-pocket for birth control.

The medication is indicated for the relief of mild to moderate pain caused by acute musculoskeletal disorders.

The findings indicate that front-line health care workers are at high risk for COVID-19 and that many health care workers with the virus may not have typical symptoms of a respiratory infection, according to the study authors.

The frequency of adverse events, such as headaches and nausea, was similar among those who received the drug (22.2%) and those who received placebos (20.5%) with no deaths in either group.

Investigators have found that although the composition and function the gut microbiome changes throughout the day in most people, these variations stop in patients with type 2 diabetes (T2D).

Each patient represents a unique set of challenges that requires focus and knowledge.

With medicinal cannabis research in its infancy, many health care providers are unsure how to provide accurate counseling and appropriate treatment to their patients.

In this episode of OnScript with NHA, co-hosts Jeremy Sasser and Jessica Langley-Loep discuss interprofessional and interdisciplinary relationships between pharmacy technicians, pharmacy interns, pharmacists, and other healthcare professionals.

Pharmacy managers should know how fickle customers can be, but also the importance of loyalty if you can create it.

At the 2020 Virtual Conference on Pediatric Health Care, Kimberly Erlich presented an update on current understandings of pharmacogenomic testing and its use as a tool in the treatment of behavioral health issues in a pediatric population.

The current pandemic has been trauma-inducing for many and telehealth needs to rise to the occasion.

Researchers conducted an online study with 371 participants who viewed a COVID-19 screening session between a hotline agent, chatbot or human, and a user with mild or severe symptoms, according to a press release.

Leung added that this is the first study to show the potential beneficial effects of ACE inhibitors and ARBs on colorectal cancer development, based on a large group of patients who were colorectal cancer-free at the beginning of the study.

Health care compliance analytics can be used to roll out institution-wide training and education programs to deter sloppy or nefarious behavior related to controlled substances.

Pharmacy Times spoke with Adam Martin, the Fit Pharmacist, about burnout prevention and stress management.

The presence of ctDNA and CTCs in the plasma of the blood of women who have undergone chemotherapy prior to surgery for the treatment of triple-negative breast cancer (TNBC) are critical indicators in the prediction of disease recurrence and disease-free survival.

Expanded Medicaid program in Michigan found to largely benefit the most vulnerable patients.

The inhaler sends data back to a mobile app in real time.

The widespread use of OTC products and dietary supplements are opportunities for pharmacists to educate patients and other health care members as to how these products fit into the overall health continuum.

Initiated in Arkansas, Rutledge v. PCMA is set to decide whether states have the authority to regulate pharmacy benefit managers.

If successful in clinical trials and pending regulatory approval, Pfizer Inc and BioNTech expect to manufacture up to 100 million doses of a COVID-19 vaccine by the end of 2020.

Mylan plans to launch adalimumab-fkjp in the United States in July 2023.

Patients can be aided by health care providers with preventable measures to reduce the chance of infectious risk.